Skybiotech Healthcare Ltd

Skybiotech Healthcare Ltd

Skybiotech Healthcare Ltd has submitted its unaudited financial results for the half year ended on 30th September 2026, as per Regulation 33 of SEBI (LODR) Regulations, 2015. The results were approved by the Board of Directors at their meeting held on 10th November 2026.

Skybiotech Healthcare Ltd

Skybiotech Healthcare Ltd has submitted its unaudited financial results for the quarter and half year ended 30th September 2026. The results were approved by the Board of Directors at their meeting held on 10th November 2026.

Skybiotech Healthcare Ltd

Skybiotech Healthcare Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 10/11/2026 to consider and approve Un-Audited Financials for the quarter ended on 30th September, 2026

Skybiotech Healthcare Ltd

Skybiotech Healthcare Ltd has submitted a certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018, confirming the dematerialization of securities for the quarter ended September 30, 2026.

Skybiotech Healthcare Ltd

Skybiotech Healthcare Ltd has submitted the Scrutinizer Report for the 43rd Annual General Meeting held on 30th September, 2026, disclosing the voting results for the FY 2025-26 resolutions.

Skybiotech Healthcare Ltd

Skybiotech Healthcare Ltd has closed its trading window due to the upcoming declaration of unaudited financial results for the quarter ended 30th September, 2026. The trading window will remain closed until 48 hours after the declaration of the results.

Skybiotech Healthcare Ltd

Skybiotech Healthcare Ltd held its 43rd Annual General Meeting on September 30, 2026, where the company's name change from Kapil Cotex Ltd was approved. The meeting was attended by 7 members, and the chairman declared that the requisite quorum was present. The company secretary informed the members that electronic copies of the annual report for the financial year 2025-26 had been sent to all registered members. The chairman also informed the members about the company's name change and the certificate from a practicing chartered accountant confirming compliance with the conditions specified under Regulation 45(1) of the SEBI LODR Regulations.

Skybiotech Healthcare Ltd

Skybiotech Healthcare Ltd has announced the outcome of its 43rd Annual General Meeting (AGM) held on September 30, 2026, where the shareholders approved the audited financial statements, re-appointed a director, and appointed a new statutory auditor.

Skybiotech Healthcare Ltd

Skybiotech Healthcare Ltd has announced its un-audited financial results for the quarter ended June 30, 2026, which were approved by the board of directors in a meeting held on August 14, 2026.

Skybiotech Healthcare Ltd

Skybiotech Healthcare Ltd has announced the outcome of its board meeting held on August 14, 2026, where it considered and approved the un-audited financial results for the quarter ended June 30, 2026.

Skybiotech Healthcare Ltd

Skybiotech Healthcare Ltd has scheduled a board meeting on August 14, 2026, to consider and approve un-audited financial results and a limited review report for the quarter ended June 30, 2026.